Literature DB >> 17699245

Associations between demographic factors and provider structures on cost and length of stay for hemodialysis patients with vascular access failure.

Louis Brenner1, Ajay K Singh, Dennis Campbell, Frances Frei, Wolfgang C Winkelmayer.   

Abstract

Vascular access failure (VAF) is a major determinant of morbidity and cost for hemodialysis patients, but little is known about the care patterns and cost implications that are associated with VAF. A total of 952 episodes of VAF in 348 patients were identified using specific procedure codes. Demographic and care pattern characteristics were available as were detailed costs for each episode. The determinants of several important performance measures were evaluated: Cost per episode, inpatient versus outpatient treatment, and length of stay (LOS). Over 5 yr of study, the proportion of VAF episodes that were treated on an outpatient basis increased from 31 to 63%. Average costs of outpatient versus inpatient episodes were $1491 and $8265, respectively. Men were more likely to be treated as outpatients (odds ratio [OR] 1.56; 95% confidence interval [CI] 1.17 to 2.08), but once admitted, their LOS was longer (difference LOS +1.3; 95% CI +0.32 to +2.28) and more costly (delta$ +2603; 95% CI +632 to +4573). Nonblack, nonwhite patients were more likely to be treated as outpatients than were white patients (OR 2.07; 95% CI 1.27 to 3.36) and had shorter LOS once admitted (deltaLOS -2.37; 95% CI -4.23 to -0.49). Compared with Medicare, non-Medicare case-managed insurance was associated with a higher likelihood of outpatient treatment (OR 1.40; 95% CI 1.01 to 1.94) for VAF and shorter LOS (deltaLOS -1.36; 95% CI -2.48 to -0.24) and lower costs (delta$ -2742; 95% CI -5012 to -472) for inpatient treatment. It is concluded that gender and racial factors may influence VAF care. Over time, more VAF episodes are being treated in outpatient settings. Case management may lead to more outpatient treatment and shorter inpatient treatment of VAF.

Entities:  

Mesh:

Year:  2006        PMID: 17699245     DOI: 10.2215/CJN.01401005

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  4 in total

1.  Intradialytic hypotension and vascular access thrombosis.

Authors:  Tara I Chang; Jane Paik; Tom Greene; Manisha Desai; Fritz Bech; Alfred K Cheung; Glenn M Chertow
Journal:  J Am Soc Nephrol       Date:  2011-08       Impact factor: 10.121

2.  Safety and efficacy of arteriovenous fistula angioplasties performed by nephrologists: report from a Brazilian interventional nephrology center.

Authors:  Ricardo P Franco; Miguel C Riella; Domingos C Chula; Marcia T de Alcântara; Marcelo M do Nascimento
Journal:  J Bras Nefrol       Date:  2022 Apr-Jun

3.  Clinical Experience with a Hybrid Procedure Using the Adherent Clot Catheter for Salvage of Thrombosed Hemodialysis Access: A Comparison with the Standard Fogarty Balloon Catheter.

Authors:  Yu Sung Yang; Kyu Dam Han; Eun Hye Choi; Young Sam Park; Yeon Ho Seo; Cheol Seung Kim
Journal:  Vasc Specialist Int       Date:  2015-03-31

4.  Epidemiology of haemodialysis catheter complications: a survey of 865 dialysis patients from 14 haemodialysis centres in Henan province in China.

Authors:  Kai Wang; Pei Wang; Xianhui Liang; Xiaoqing Lu; Zhangsuo Liu
Journal:  BMJ Open       Date:  2015-11-20       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.